Drugs / CAdVEC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03740256 | Dec 2020 → Dec 2026 expected | breast cancer, colorectal cancer, esophageal cancer, gastric cancer +5 | Baylor College of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAdVEC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03740256 ↗ |
| Route | Other | “The intratumoral administration of CAdVEC” NCT03740256 ↗ |